S&P 500 & Eli Lilly and Company
7 shared events · Importance 5 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
S&P 500: The S&P 500 advanced, moving above key technical levels, reflecting positive market sentiment driven by Middle East peace talks and strong performance in certain sectors.
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
Apr 01, 2026 · 14 articles
International
S&P 500: The S&P 500 experienced significant drops, including its first back-to-back decline in three weeks, due to the sell-off in AI stocks and broader market concerns.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Jun 03, 2026 · 191 articles
Domestic
S&P 500: The S&P 500 edged up to an all-time closing high, reflecting overall market strength despite some concerns about AI-related stocks.
Eli Lilly and Company: Eli Lilly and Company saw gains that helped offset drops in other sectors, contributing to the overall positive market performance.
Dec 11, 2025 · 7 articles
NEWSDESK
Explore this relationship live
Track how S&P 500 and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard